Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Core Scientific (CORZW) Invested Capital (2020 - 2025)

Core Scientific (CORZW) has disclosed Invested Capital for 6 consecutive years, with -$962.7 million as the latest value for Q4 2025.

  • Quarterly Invested Capital fell 2.27% to -$962.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$962.7 million through Dec 2025, down 2.27% year-over-year, with the annual reading at -$962.7 million for FY2025, 2.27% down from the prior year.
  • Invested Capital hit -$962.7 million in Q4 2025 for Core Scientific, up from -$1.3 billion in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $1.3 billion in Q4 2021 to a low of -$1.3 billion in Q3 2025.
  • Historically, Invested Capital has averaged -$291.5 million across 5 years, with a median of -$377.7 million in 2023.
  • Biggest five-year swings in Invested Capital: skyrocketed 1403.19% in 2021 and later crashed 348.5% in 2023.
  • Year by year, Invested Capital stood at $1.3 billion in 2021, then tumbled by 130.52% to -$409.3 million in 2022, then plummeted by 32.27% to -$541.4 million in 2023, then crashed by 73.87% to -$941.4 million in 2024, then decreased by 2.27% to -$962.7 million in 2025.
  • Business Quant data shows Invested Capital for CORZW at -$962.7 million in Q4 2025, -$1.3 billion in Q3 2025, and -$1.2 billion in Q2 2025.